ID: ALA5281403

Max Phase: Preclinical

Molecular Formula: C17H18O6

Molecular Weight: 318.33

Associated Items:

Representations

Canonical SMILES:  COC(C)(C)C(O)COc1c2ccoc2cc2oc(=O)ccc12

Standard InChI:  InChI=1S/C17H18O6/c1-17(2,20-3)14(18)9-22-16-10-4-5-15(19)23-13(10)8-12-11(16)6-7-21-12/h4-8,14,18H,9H2,1-3H3

Standard InChI Key:  UHENVVIVPZCJOA-UHFFFAOYSA-N

Associated Targets(non-human)

Human immunodeficiency virus 3636 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 318.33Molecular Weight (Monoisotopic): 318.1103AlogP: 2.70#Rotatable Bonds: 5
Polar Surface Area: 82.04Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.23CX Basic pKa: CX LogP: 1.80CX LogD: 1.80
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.73Np Likeness Score: 1.58

References

1. Hassan MZ, Osman H, Ali MA, Ahsan MJ..  (2016)  Therapeutic potential of coumarins as antiviral agents.,  123  [PMID:27484512] [10.1016/j.ejmech.2016.07.056]

Source